The first drug produced in the laboratory in the world, in 1987, was acetylsalicylic acid, known as aspirin, after long years of research. In 2023, with the help of artificial intelligence (AI) and machine learning, in Portuguese, machine learning, the promise is a revolution in the field of pharmaceutical and biotechnology industry, with promises from Pfizer to produce medicines with AI!
Advances in the field of medicine
see more
'Barbie' movie predicted to boost Mattel profits…
Japanese company imposes time restriction and reaps benefits
With the advancement of scientific research, provided by technological growth, it is already possible to think about the discovery of fundamental remedies to save people's lives, from the use of artificial intelligence and machine learning. The idea is to intensify and consolidate the use of technology in the area of research.
Based on this vision, companies such as Pfizer seek to develop new drugs with the help of artificial intelligence predictions. The central point is the search for enough information to promote the tracking of molecules likely to cure certain diseases.
During the COVID-19 pandemic, Pfizer's vaccine was among the most effective in reducing serious complications from coronavirus. However, it was with the help of technology that the pharmaceutical giant was able to produce all the necessary input for the vaccine in time.
According to Djork-Arné Clevert, vice president of machine learning at Pfizer Inc., artificial intelligence assists in the work of researchers by indicating what should be explored or left aside when producing medicines.
Due to the potential for accumulation and storage of data by artificial intelligence and machine learning, it is possible to identify how molecules can act in the body and how they act in the fight against certain diseases. The expectation is that the algorithms will also help with new biological discoveries.
However, Pfizer also wants to use artificial intelligence to study diseases and other medical problems that still don't have a sufficiently available database. For this, they have the help of deep learning technology or deep learning, in Portuguese.
After the predictions acquired through artificial intelligence, Pfizer seeks to combine the experience of the researchers to obtain greater accuracy of the data and ensure the best development of the medications.
American multinational has more than 174 years
Pfizer became well known in 2020 after the development of vaccines for COVID-19. However, the pharmaceutical multinational was founded on January 1, 1849 by German immigrants Charles Pfizer and Charles Erhart, in New York, in the United States.
